Follow the Standard Biotools INC. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Operating in the Energy sector, Standard Biotools INC. has logged 148 public disclosures. Market capitalisation: €262.6m. The latest transaction was reported on 24 August 2026 (Retenue fiscale). Among the most active insiders: Casdin Partners Master Fund, L.P.. The full history is free.
148
Insider Decl.
n/a
Thresholds
€20m
33 ops.
Buy Volume
€34,197
6 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Standard Biotools INC. Hold (neutral), based on 1 analysts. Average price target: US$1.35.
35Σ signal
Buys €20m€34,197 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,112 of 29,055 companies
18.1
score / 100
Value
7
Quality
29
FCF yld-33%
Earn yld-30%
EV/EBITDA·
ROE-11%
Gross mgn50%
Net mgn-88%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
150,000 shares@ US$1.43250.2% of flowCommon Stock, $0.001 par value per shareSEC:0000919574-25-007187:0
Canonical exit: 22 Feb 2026 (T+90)
25 of 148 declarations
Acerca de Standard Biotools INC.
Standard Biotools INC. es una empresa enfocada en el sector energético, que ofrece soluciones innovadoras para el desarrollo sostenible. Cotiza en el mercado XNAS.